US Broker Ratings

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 26% Upside Potential Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a stalwart in the healthcare sector, particularly in diagnostics and research, is capturing the attention of investors with its promising growth trajectory. Headquartered in Westbrook,..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 32.54% Potential Upside for Investors

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, is catching the eyes of investors with its promising potential upside of 32.54%, according to the latest analyst ratings. With..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating Growth Potential Amidst a 20% Upside Forecast

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis services and products, stands as a key player in the healthcare sector, particularly within the niche of renal..

AstraZeneca PLC (AZN) Stock Analysis: Robust Revenue Growth and a 20.73% Upside Potential

AstraZeneca PLC (AZN) presents a compelling case for investors seeking opportunities within the healthcare sector. With its headquarters in Cambridge, United Kingdom, this biopharmaceutical titan boasts a market capitalization of..

Alcon Inc. (ALC) Stock Analysis: Healthcare Giant with 32.5% Upside Potential

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor interest with a sizeable market capitalization of $32.58..

Centene Corporation (CNC) Stock Analysis: A Healthcare Giant’s Strategic Position Amidst Market Challenges

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, is navigating a complex market landscape with a market capitalization of $30.78 billion. The St. Louis-based company, founded..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with 59% Potential Upside

Investors in the healthcare sector may want to take a closer look at Insulet Corporation (NASDAQ: PODD), a company renowned for its innovative insulin delivery systems. With a market capitalization..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Potential Amid Strong Revenue Performance

For individual investors keen on the biotechnology sector, Incyte Corporation (NASDAQ: INCY) presents a compelling case with its promising revenue growth and robust product pipeline. With a market capitalization of..

Eli Lilly (LLY) Stock Analysis: A Healthcare Giant with 7.4% Potential Upside and Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its impressive market performance and promising growth prospects. As a leading player..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Competitive Healthcare Landscape with Strong Buy Ratings

Elevance Health, Inc. (NYSE: ELV), a formidable player in the healthcare sector, continues to command investor attention with its diversified offerings and strategic positioning in the healthcare plans industry. With..

Stryker Corporation (SYK) Stock Analysis: A Healthcare Giant with 27.57% Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector, is a medical devices juggernaut with a market capitalization of $117.18 billion. Headquartered in Portage, Michigan, Stryker has carved a..

Baxter International Inc. (BAX): Investor Outlook Shows 11.15% Potential Upside Amid Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to present intriguing opportunities for investors navigating the medical instruments and supplies industry. With a market capitalization of..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth with a 9.90% Revenue Surge and an 8.63% Potential Upside

Investors eyeing Johnson & Johnson (NYSE: JNJ) will find a resilient healthcare giant poised for continued growth. With a market capitalization of $560.33 billion, J&J stands as a stalwart in..

United Therapeutics Corporation (UTHR) Stock Analysis: Investor Outlook on Robust Growth Potential with 20.98% Upside

United Therapeutics Corporation (NASDAQ: UTHR) continues to intrigue investors with its innovative approach to treating chronic and life-threatening diseases. As a key player in the healthcare sector, United Therapeutics specializes..

Mettler-Toledo International (MTD) Stock Analysis: A 15% Upside Potential in Diagnostics & Research

Mettler-Toledo International Inc. (NYSE: MTD), a titan in the precision instruments sector, offers an intriguing proposition for investors with its robust growth potential and strategic market positioning. Headquartered in Greifensee,..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Potential 91.97% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) has emerged as a notable player in the biotechnology sector, particularly for investors keeping a keen eye on high-growth potential stocks. Based in Miami, Florida,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 22.80% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology sector, continues to captivate investor interest with its robust growth trajectory and expansive product pipeline. With a market capitalization..

McKesson Corporation (MCK) Stock Analysis: Exploring a 22.44% Potential Upside with Strong Buy Ratings

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, operating within the medical distribution industry. With a market capitalization of $93.24 billion, McKesson is a key..

Veeva Systems Inc. (VEEV) Stock Analysis: Unveiling a 43.84% Potential Upside in the Healthcare Cloud Software Sector

Veeva Systems Inc. (VEEV) stands as a formidable player in the healthcare technology sector, offering a suite of cloud-based software solutions primarily aimed at the life sciences industry. With a..

argenx SE (ARGX)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds